Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

245
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
245
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

309
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
309
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

6.1K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GABAergic Modulation of Brain Function During Prosaccade and Antisaccade Eye Movements: Evidence From Ultra-High-Field fMRI.

Human brain mapping·2026
Same author

Digital Acceptance and Commitment Therapy for the Treatment of Chronic Pain: Findings of a Randomized Controlled Efficacy Trial.

Deutsches Arzteblatt international·2026
Same author

Mobile App-Guided Exposure Therapy for Panic Disorder With and Without Agoraphobia: Randomized Controlled Trial.

Journal of medical Internet research·2025
Same author

[Therapy and healthcare applications in the treatment of adult attention deficit hyperactivity disorder: a review].

Der Nervenarzt·2025
Same author

Developing Advanced AI Ecosystems to Enhance Diagnosis and Care for Patients with Depression.

Studies in health technology and informatics·2023
Same author

[Prescription-based digital interventions in psychiatry : Methodology, possible areas of application, and legal framework of digital tools for panic disorder and agoraphobia available in Germany].

Der Nervenarzt·2023

Related Experiment Video

Updated: Jan 17, 2026

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.2K

[Digital therapeutics in Neurology].

Matthias Guth

    Fortschritte Der Neurologie-Psychiatrie
    |January 14, 2026
    PubMed
    Summary

    Germany now allows doctors to prescribe digital health interventions for neurological conditions. These approved digital therapies must meet strict safety, privacy, and effectiveness standards for patient care.

    Area of Science:

    • Neurology
    • Digital Health
    • Healthcare Policy

    Background:

    • Since 2020, German physicians and psychotherapists can prescribe digital interventions.
    • These interventions require rigorous safety, data privacy, and proven effectiveness.
    • Digital therapeutics offer new treatment avenues for various neurological and cognitive conditions.

    Purpose of the Study:

    • To outline the current landscape of approved digital interventions in Germany.
    • To detail the types of neurological conditions addressed by these digital tools.
    • To inform healthcare providers about the availability and scope of digital therapeutics.

    Main Methods:

    • Review of available digital interventions approved for prescription in Germany.
    • Categorization of interventions based on the neurological condition treated.

    More Related Videos

    Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
    10:28

    Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

    Published on: July 24, 2019

    16.0K
    Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
    14:14

    Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

    Published on: August 12, 2018

    9.3K

    Related Experiment Videos

    Last Updated: Jan 17, 2026

    Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
    05:19

    Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

    Published on: July 7, 2023

    3.2K
    Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
    10:28

    Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

    Published on: July 24, 2019

    16.0K
    Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
    14:14

    Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

    Published on: August 12, 2018

    9.3K
  • Summary of regulatory requirements for digital health solutions.

    • Main Results:

    • Eight digital interventions are currently approved in neurology.
    • These include treatments for multiple sclerosis (elevida, levidex), insomnia (HelloBetter Schlafen, somnio, somnovia), aphasia (neolexon Aphasie), mild cognitive impairment (NeuroNation MED), and migraine prophylaxis (sinCephalea).
    • Digital interventions can be used for outpatient and post-hospital treatment.

    Conclusions:

    • Germany has established a framework for prescribing evidence-based digital interventions in neurology.
    • A growing number of digital therapeutics are available for specific neurological conditions.
    • These digital solutions expand treatment options for patients in both outpatient and post-acute care settings.